The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $133.66

Today's change+1.89 +1.43%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $133.66

Today's change+1.89 +1.43%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.

Core Laboratories NV Hits New 52-week High

Core Laboratories NV closed up Friday by (U.S.)$1.89 or 1.43% to (U.S.)$133.66 and setting a new 52-week high. Over the last five days, shares have gained 3.44% and are currently 1.35% off of the 52-week high. Shares have outperformed the S&P 500 by 5.25% during the last year.

Key company metrics

  • Open(U.S.) $133.25
  • Previous close(U.S.) $131.77
  • High(U.S.) $135.49
  • Low(U.S.) $131.80
  • Bid / Ask(U.S.) $126.75 / (U.S.) $139.95
  • YTD % change+22.92%
  • Volume661,447
  • Average volume (10-day)755,312
  • Average volume (1-month)586,214
  • Average volume (3-month)731,766
  • 52-week range(U.S.) $84.50 to (U.S.) $135.49
  • Beta1.42
  • Trailing P/E57.93×
  • P/E 1 year forward83.15×
  • Forward PEG4.16×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield1.65%
  • Trailing EPS(U.S.) $2.31
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:EnergyIndustry:Oil Related Services & Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue154183197204
Total other revenue--------
Total revenue154183197204
Gross profit41586869
Total cost of revenue113125129135
Total operating expense131159150156
Selling / general / administrative11121213
Research & development--------
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)01600
Other operating expenses, total0-101
Operating income23244748
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax20204345
Income after tax15163435
Income tax, total451010
Net income15153335
Total adjustments to net income--------
Net income before extra. items15153335
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items15153335
Inc. avail. to common incl. extra. items15153335
Diluted net income15153335
Dilution adjustment--------
Diluted weighted average shares43434343
Diluted EPS excluding extraordinary itemsvalue per share0.350.360.780.81
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.350.650.780.80